Terms: = Ovarian cancer AND MS4A1, B1, Bp35, CD20, CVID5, LEU-16, MS4A2, S7 AND Clinical Outcome
4 results:
1. Application of Immunoprofiling Using Multiplexed Immunofluorescence Staining Identifies the Prognosis of Patients with High-Grade Serous ovarian cancer.
Lee SW; Lee HY; Kang SW; Kim MJ; Lee YJ; Sung CO; Kim YM
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502561
[TBL] [Abstract] [Full Text] [Related]
2. Tumor-Infiltrated Lymphocytes, Macrophages, and Dendritic Cells in Endometrioid Adenocarcinoma of Corpus Uteri as Potential Prognostic Factors: An Immunohistochemical Study.
Zinovkin D; Pranjol MZ
Int J Gynecol Cancer; 2016 Sep; 26(7):1207-12. PubMed ID: 27465886
[TBL] [Abstract] [Full Text] [Related]
3. p70 S6 kinase drives ovarian cancer metastasis through multicellular spheroid-peritoneum interaction and P-cadherin/b1 integrin signaling activation.
Ip CK; Yung S; Chan TM; Tsao SW; Wong AS
Oncotarget; 2014 Oct; 5(19):9133-49. PubMed ID: 25193855
[TBL] [Abstract] [Full Text] [Related]
4. Gains and losses of CD8, cd20 and CD56 expression in tumor stroma-infiltrating lymphocytes compared with tumor-associated lymphocytes from ascitic fluid and lymphocytes from tumor draining lymph nodes in serous papillary ovarian carcinoma patients.
Papadopoulos N; Kotini A; Cheva A; Jivannakis T; Manavis J; Alexiadis G; Lambropoulou M; Vavetsis S; Tamiolakis D
Eur J Gynaecol Oncol; 2002; 23(6):533-6. PubMed ID: 12556098
[TBL] [Abstract] [Full Text] [Related]
